Prepare for the Future: Dissecting the Spike to Seek Broadly Neutralizing Antibodies and Universal Vaccine for Pandemic Coronaviruses
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Prepare for the Future: Dissecting the Spike to Seek Broadly Neutralizing Antibodies and Universal Vaccine for Pandemic Coronaviruses
Authors
Keywords
-
Journal
Frontiers in Molecular Biosciences
Volume 7, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-09-01
DOI
10.3389/fmolb.2020.00226
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Analysis of a Therapeutic Antibody Cocktail Reveals Determinants for Cooperative and Broad Ebolavirus Neutralization
- (2020) Pavlo Gilchuk et al. IMMUNITY
- The protective potential of Fc‐mediated antibody functions against influenza virus and other viral pathogens
- (2020) Hillary A Vanderven et al. IMMUNOLOGY AND CELL BIOLOGY
- Is COVID-19 receiving ADE from other coronaviruses?
- (2020) Jason A. Tetro MICROBES AND INFECTION
- Covid-19 — Navigating the Uncharted
- (2020) Anthony S. Fauci et al. NEW ENGLAND JOURNAL OF MEDICINE
- The costs of secrecy
- (2020) H. Holden Thorp SCIENCE
- Structural basis for the recognition of the SARS-CoV-2 by full-length human ACE2
- (2020) Renhong Yan et al. SCIENCE
- Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
- (2020) Daniel Wrapp et al. SCIENCE
- Broadly Protective Strategies Against Influenza Viruses: Universal Vaccines and Therapeutics
- (2020) Olivia A. Vogel et al. Frontiers in Microbiology
- Vaccines and Broadly Neutralizing Antibodies for HIV-1 Prevention
- (2020) Kathryn E. Stephenson et al. Annual Review of Immunology
- A Vaccine against Ebola Virus
- (2020) Erica Ollmann Saphire CELL
- Structural and Functional Basis of SARS-CoV-2 Entry by Using Human ACE2
- (2020) Qihui Wang et al. CELL
- A Genomic Perspective on the Origin and Emergence of SARS-CoV-2
- (2020) Yong-Zhen Zhang et al. CELL
- Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein
- (2020) Alexandra C. Walls et al. CELL
- Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion
- (2020) Shuai Xia et al. CELL RESEARCH
- Probable Pangolin Origin of SARS-CoV-2 Associated with the COVID-19 Outbreak
- (2020) Tao Zhang et al. CURRENT BIOLOGY
- Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19)
- (2020) James M. Sanders et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Forty years with coronaviruses
- (2020) Susan R. Weiss JOURNAL OF EXPERIMENTAL MEDICINE
- Will COVID-19 generate global preparedness?
- (2020) Kathryn H Jacobsen LANCET
- Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody
- (2020) Dora Pinto et al. NATURE
- Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor
- (2020) Jun Lan et al. NATURE
- The proximal origin of SARS-CoV-2
- (2020) Kristian G. Andersen et al. NATURE MEDICINE
- Developing Covid-19 Vaccines at Pandemic Speed
- (2020) Nicole Lurie et al. NEW ENGLAND JOURNAL OF MEDICINE
- Better late than never
- (2020) H. Holden Thorp SCIENCE
- A highly conserved cryptic epitope in the receptor binding domains of SARS-CoV-2 and SARS-CoV
- (2020) Meng Yuan et al. SCIENCE
- A human monoclonal antibody blocking SARS-CoV-2 infection
- (2020) Chunyan Wang et al. Nature Communications
- Covid-19: FDA approves use of convalescent plasma to treat critically ill patients
- (2020) Janice Hopkins Tanne BMJ-British Medical Journal
- Lessons learned from Zaire ebolavirus to help address urgent needs for vaccines against Sudan ebolavirus and Marburg virus
- (2020) Daniel N. Wolfe et al. Human Vaccines & Immunotherapeutics
- Recent advances in “universal” influenza virus antibodies: the rise of a hidden trimeric interface in hemagglutinin globular head
- (2020) Yulu Wang et al. Frontiers of Medicine
- Potent anti-influenza H7 human monoclonal antibody induces separation of hemagglutinin receptor-binding head domains
- (2019) Hannah L. Turner et al. PLOS BIOLOGY
- Achieving cross-reactivity with pan-ebolavirus antibodies
- (2019) Liam B King et al. Current Opinion in Virology
- Structural basis of broad ebolavirus neutralization by a human survivor antibody
- (2019) Brandyn R. West et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Ebola virus disease
- (2019) Denis Malvy et al. LANCET
- Unexpected Receptor Functional Mimicry Elucidates Activation of Coronavirus Fusion
- (2019) Alexandra C. Walls et al. CELL
- Protein and Glycan Mimicry in HIV Vaccine Design
- (2019) Gemma E. Seabright et al. JOURNAL OF MOLECULAR BIOLOGY
- A pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike
- (2019) Shuai Xia et al. Science Advances
- New antibody-based prevention and treatment options for influenza
- (2019) Koen Sedeyn et al. ANTIVIRAL RESEARCH
- The Quest for a Truly Universal Influenza Vaccine
- (2019) Yo Han Jang et al. Frontiers in Cellular and Infection Microbiology
- Molecular Mechanism for Antibody-Dependent Enhancement of Coronavirus Entry
- (2019) Yushun Wan et al. JOURNAL OF VIROLOGY
- A Randomized, Controlled Trial of Ebola Virus Disease Therapeutics
- (2019) Sabue Mulangu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Broadly neutralizing antibodies and vaccine design against HIV-1 infection
- (2019) Qian Wang et al. Frontiers of Medicine
- Multifunctional Pan-ebolavirus Antibody Recognizes a Site of Broad Vulnerability on the Ebolavirus Glycoprotein
- (2018) Pavlo Gilchuk et al. IMMUNITY
- Broadly neutralizing antibodies from human survivors target a conserved site in the Ebola virus glycoprotein HR2–MPER region
- (2018) Andrew I. Flyak et al. Nature Microbiology
- Systematic Analysis of Monoclonal Antibodies against Ebola Virus GP Defines Features that Contribute to Protection
- (2018) Erica Ollmann Saphire et al. CELL
- Native-like Env trimers as a platform for HIV-1 vaccine design
- (2017) Rogier W. Sanders et al. IMMUNOLOGICAL REVIEWS
- Cryo-EM structures of MERS-CoV and SARS-CoV spike glycoproteins reveal the dynamic receptor binding domains
- (2017) Yuan Yuan et al. Nature Communications
- Structure and Function Analysis of an Antibody Recognizing All Influenza A Subtypes
- (2016) Nicole L. Kallewaard et al. CELL
- Novel universal influenza virus vaccine approaches
- (2016) Florian Krammer Current Opinion in Virology
- Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC
- (2013) V. Stalin Raj et al. NATURE
- Human Monoclonal Antibodies against Highly Conserved HR1 and HR2 Domains of the SARS-CoV Spike Protein Are More Broadly Neutralizing
- (2012) Hatem A. Elshabrawy et al. PLoS One
- Influenza Virus Evolution, Host Adaptation, and Pandemic Formation
- (2010) Jeffery K. Taubenberger et al. Cell Host & Microbe
- Vaccine-induced enhancement of viral infections
- (2008) W. Huisman et al. VACCINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now